TSX.V: DME U.S. OTC: DMEHF Frankfurt: QM01 VANCOUVER, BC, March 17, 2025 /PRNewswire/ – DESERT MOUNTAIN ENERGY CORP. (the “Company”) (TSXV: DME) (OTC: DMEHF) (Frankfurt: QM01) From the President of the Company. Desert Mountain Energy Corp. is pleased to announce significant progress on…
Tag: PR Newswire
NEW YORK, March 17, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of bluebird bio, inc. (“bluebird” or the “Company”) (NASDAQ: BLUE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, March 17, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Parsons Corporation (“Parsons” or the “Company”) (NYSE: PSN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, March 17, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of TFI International Inc (“TFI” or the “Company”) (NYSE: TFII). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, March 17, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Perpetua Resources Corp (“Perpetua” or the “Company”) (NASDAQ: PPTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, March 17, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, March 17, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Septerna, Inc (“Septerna” or the “Company”) (NASDAQ: SEPN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, March 17, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Voyager Therapeutics, Inc (“Voyager” or the “Company”) (NASDAQ: VYGR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
BLOOMINGTON, Ind., March 17, 2025 /PRNewswire/ — Solution Tree, a leading educational publisher and professional development provider, announced today that its longtime CEO, Jeff Jones, will step down from the role effective March 31 to lead the company’s newly established board of…
PITTSBURGH, March 17, 2025 /PRNewswire/ — “I thought there could be a better way to keep headphones or ear protection in place on the head when wearing a hat,” said an inventor, from Richmond, Ky., “so I invented the NESSO. My design prevents the hassle and discomfort associated with…
